Synagis
- Licence status
- Withdrawn: 26/01/2023
- Active substances
- Palivizumab
- Dosage Form
- Powder and solvent for solution for injection
- Licence number
- EU/1/99/117/002
- Licence holder
- AstraZeneca AB
Licence information
- ATC code
- J06BB Specific immunoglobulins, J06BB16 palivizumab
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 13/08/1999